Effectiveness of penfluridol (oral long acting neuroleptic) as compared to second generation oral neuroleptics in psychotic disorder patients: an open label randomized controlled trial.
- Conditions
- Psychotic disorder10039628
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 180
In order to be eligible to participate in this study, a subject must meet all of the following criteria:;1. age 18-65 years
2. psychotic disorder, including schizophrenia, schizoaffective disorder, delusional disorder or psychosis not otherwise specified
3. treatment on an outpatient basis (at the start of the study)
4. psychiatrist treating the patient decides that it is appropriate (based on clinical judgement, guidelines, history and symptoms of the patient) to prescribe either penfluridol, olanzapine or risperidone and that there a no decisive contra-indications
5. patient is willing to use oral neuroleptic treatment, including penfluridol, olanzapine or risperidone
6. able to give informed consent
A potential subject who meets any of the following criteria will be excluded from participation in this study:;1.judicial order stating that taking medication is obliged
2.patient did use penfluridol during the previous six months
3.serious and unstable somatic medical condition
4.insufficient proficiency in Dutch language
5.women who are pregnant
6. patient is on adequate antipsychotic therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method